Author Details :
Volume : 7, Issue : 1, Year : 2020
Article Page : 24-32
Introduction: Colorectal malignancies stand out to be one of the chief causes of morbidity and mortality
in the world. Although the total incidence of colorectal malignancy in India n population has marginally
increased, it is now a common cause of cancer mortality among Indians.
The oncogene HER2/neu belongs to the tyrosine kinase receptor family. The favorable outcome of
HER2/neu in management of breast carcinoma patients has direct ed to evaluation of gene amplification
protein overexpression, and anti-tumor activity of Herceptin in various tumor types one amongst which
is colorectal carcinomas. The objective of the study was to evaluate the frequency of overexpression of
HER2/neu in colorectal adenocarcinomas (CRC) and its association with various histomorphological and
Materials and Methods: A total of 52 cases of colorectal adenocarcinomas including colonoscopic
biopsies & resected specimens were studied. Paraffin embedded sections were stained with Hematoxylin &
Eosin and histological and clinicopathological parameters were assessed. In IHC, antigens were retrieved
by Heat Induced Epitope Retrieval method and HER2/ neu status was determined using a semiquantitative
scoring system. The scores were then correlated with histological grade, type and clinicopathological
Results: The HER2/neu overexpression was noted in 53.8% of our cases and was seen to be commonly
expressed by moderately differentiated tumours and conventional/ NOS histological type.
There was a statistically significant correlation observed between HER2/neu status and tumour grade (p=
0.001), tumour type (p = 0.008). There was no significant correlation between age, gender or localisation
or stage of tumour.
Conclusion: Histological grade and histological type of CRC showed a significant correlation with
HER2/neu overexpression, hence can be used as a predictive tool for determining the prognosis of the
Patients who overexpress HER2/neu could become potential candidates for this monoclonal antibody based
targeted immunotherapy thus reduce overall mortality and morbidity of CRC worldwide.
Keywords: HER2/neu, Colorectal adenocarcinoma.
How to cite : Neha Ratan B, Suranagi V V, Frequency of overexpression of Her2/neu in colorectal adenocarcinomas– A hospital based cross-sectional study. Indian J Pathol Oncol 2020;7(1):24-32
Copyright © 2020 by author(s) and Indian J Pathol Oncol. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)